Skip to content

Vaxcyte, Inc. PCVX Total Assets

Total Assets at other companies

Pfizer logo
PfizerPFE
$207.62B-0.2%
Merck & Co. logo
Merck & Co.MRK
$128.69B+11.8%
Moderna logo
ModernaMRNA
$11.49B-9.6%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$1.4B+30.0%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$646.64M+113%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$26.48B+15.8%

Other financials

Income statement

See full
Operating income-$345.9M-91.3%
Net income-$320.6M-128%
EPS (diluted)-$2.30-121%

Balance sheet

See full
Cash & equivalents$262.3M-24.7%
Total debt$116.3M+33.5%
Total equity$3.0B-6.4%

Cash flow

See full
Operating cash flow-$280.6M-68.8%
CapEx$2.1M-61.2%
Free cash flow-$282.7M-64.7%

Valuation

See full
Market cap$7.43B+72.0%
Enterprise value$7.28B+78.6%

Returns & leverage

See full
Return on equity-30.6%+37.9pp
Debt / equity0.0×
Current ratio7.5×-10.2×

Where this comes from

Reported directly by Vaxcyte, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vaxcyte, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vaxcyte, Inc.'s total assets?
Vaxcyte, Inc. (PCVX) reported total assets of $3.35B in Q1 2026.
How has Vaxcyte, Inc.'s total assets changed year-over-year?
Vaxcyte, Inc.'s total assets decreased by 0.9% year-over-year, from $3.38B to $3.35B.
What is the long-term trend for Vaxcyte, Inc.'s total assets?
Over 5 years (2020 to 2025), Vaxcyte, Inc.'s total assets has grown at a 50.2% compound annual growth rate (CAGR), from $392.83M to $3B.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.